Earth Science Tech Reports Transformational Fiscal Year with Share Repurchases and Healthcare Expansion

Earth Science Tech Inc. (OTC: ETST) reported a series of operational milestones in its fiscal year ended March 31, 2026, highlighting expansion across its healthcare platform and continued cash-flow generation. The company, a strategic healthcare-oriented holding company, has spent the past several years reshaping itself from a wellness-focused enterprise into a diversified holding company centered on healthcare, pharmaceutical compounding, telemedicine, real estate, and cash-flow-generating operating businesses.

In its annual shareholder letter, CEO and Chairman Giorgio R. Saumat described fiscal 2026 as a year in which the company strengthened the foundation for future growth while maintaining a debt-free approach. Key operating businesses, including DOConsultation, Villas Health, and MOC Teledoc, are now cash-flow positive. Additionally, Peaks Curative surpassed $2 million in revenue during the first week of fiscal Q4 2026, reflecting growth within the company’s health and wellness segment.

A defining element of ETST’s capital allocation strategy has been its share repurchase program. Since fiscal Q1 2026, Earth Science Tech repurchased and retired more than 6.9 million shares of common stock, underscoring management’s focus on reducing share dilution in support of shareholder value. Management emphasized that expansion initiatives were completed without adding debt to the balance sheet, maintaining a disciplined capital structure.

The company’s transformation was a central theme of the shareholder letter, available at https://ibn.fm/WX3CI. Investors will have an opportunity to hear directly from management when CEO Giorgio R. Saumat presents at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17.

Earth Science Tech’s strategic pivot and disciplined financial management highlight a commitment to building long-term shareholder value through operational efficiency and targeted growth. The company’s ability to achieve cash-flow positivity across multiple businesses while repurchasing shares and avoiding debt positions it as a potentially resilient player in the healthcare sector.